Menu
Currency
GWAS Study

Genetic association analyses highlight biological pathways underlying mitral valve prolapse.

Dina C, Bouatia-Naji N, Tucker N et al.

26301497 PubMed ID
GWAS Study Type
12082 Participants
55 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DC
Dina C
BN
Bouatia-Naji N
TN
Tucker N
DF
Delling FN
TK
Toomer K
DR
Durst R
PM
Perrocheau M
FL
Fernandez-Friera L
SJ
Solis J
LT
Le Tourneau T
CM
Chen MH
PV
Probst V
BY
Bosse Y
PP
Pibarot P
ZD
Zelenika D
LM
Lathrop M
HS
Hercberg S
RR
Roussel R
BE
Benjamin EJ
BF
Bonnet F
LS
Lo SH
DE
Dolmatova E
SF
Simonet F
LS
Lecointe S
KF
Kyndt F
RR
Redon R
LM
Le Marec H
FP
Froguel P
EP
Ellinor PT
VR
Vasan RS
BP
Bruneval P
MR
Markwald RR
NR
Norris RA
MD
Milan DJ
SS
Slaugenhaupt SA
LR
Levine RA
SJ
Schott JJ
HA
Hagege AA
JX
Jeunemaitre X
Chapter II

Abstract

Summary of the research findings

Nonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valvulopathy of unknown etiology that predisposes to mitral regurgitation, heart failure and sudden death. Previous family and pathophysiological studies suggest a complex pattern of inheritance. We performed a meta-analysis of 2 genome-wide association studies in 1,412 MVP cases and 2,439 controls. We identified 6 loci, which we replicated in 1,422 cases and 6,779 controls, and provide functional evidence for candidate genes. We highlight LMCD1 (LIM and cysteine-rich domains 1), which encodes a transcription factor and for which morpholino knockdown of the ortholog in zebrafish resulted in atrioventricular valve regurgitation. A similar zebrafish phenotype was obtained with knockdown of the ortholog of TNS1, which encodes tensin 1, a focal adhesion protein involved in cytoskeleton organization. We also showed expression of tensin 1 during valve morphogenesis and describe enlarged posterior mitral leaflets in Tns1(-/-) mice. This study identifies the first risk loci for MVP and suggests new mechanisms involved in mitral valve regurgitation, the most common indication for mitral valve repair.

1,442 European ancestry cases, 2,439 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

12082
Total Participants
GWAS
Study Type
Yes
Replicated
1,422 European ancestry cases, 6,779 European ancestry controls
Replication Participants
European
Ancestry
U.S., Canada, U.K., Spain, France
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.